about
SLE - Complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosusNuclear factor of activated T cells - a transcription factor family as critical regulator in lung and colon cancerClinical assessment and management of cytopenias in lupus patients.Hematological disorders in patients with systemic lupus erythematosus.Haematological manifestations of lupus.ANA Negative Systemic Lupus Erythematosus Leading to CTEPH, TTP-Like Thrombocytopenia, and Skin Ulcers.Basic immunosuppressive drugs outside solid organ transplantation.Contemporary treatment of systemic lupus erythematosus: an update for clinicians.Current state of evidence on 'off-label' therapeutic options for systemic lupus erythematosus, including biological immunosuppressive agents, in Germany, Austria and Switzerland--a consensus report.The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review.Cyclosporin rapidly diminished a severe lupus-associated macrophage association syndrome refractory to pulsed methylprednisolone and intravenous immunoglobulin.The immune development in a child born to a cyclosporin A-treated woman with systemic lupus erythematosus/polymyositis.Modulation of autoantibody production by mycophenolate mofetil: effects on the development of SLE in (NZB x NZW)F1 mice.0.1% Tacrolimus ointment in a patient with subacute cutaneous lupus erythematosus.The BILAG multi-centre open randomized controlled trial comparing ciclosporin vs azathioprine in patients with severe SLE.
P2860
Q24804939-DBAB604C-3157-4C24-ABAE-A8109DC4A943Q26824937-510A4832-93CE-4FC8-9EE8-06577CA3AA5BQ33394969-78B8944A-8E8A-4F92-9E5C-D093D32318BCQ33411323-3FC9B71D-8688-4922-92D5-5D8FA47D8B89Q33421876-13E6AAC0-3518-4570-9B6F-730BD4B7D786Q33430964-4B5C8325-8D5E-4BE1-86DA-1373CA3E1FB7Q36407314-4A5FAE1B-E3E8-4DB7-BD47-C7A3861B2164Q36443689-FA6CAE39-E24D-4E31-BFF0-09FFE2719215Q37954539-E96C8297-567B-4B15-A27D-94B9D6547D77Q38925320-22680489-7086-4B9E-A58A-FE54926E83C2Q43239645-C532FE08-A40C-4D56-B0E3-91ACBBFEADFBQ44114234-F76C9A97-4B8A-4116-9BD2-76DB9B99D7CCQ44397965-F8B542B3-E6F4-48A3-9900-678AE3E72984Q44750223-3F98DCD4-D273-4C26-BA59-05E4D4222553Q45821336-CF7AA73D-4C49-4D87-BAE4-8E689609B91C
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The treatment of lupus with cyclosporin A.
@ast
The treatment of lupus with cyclosporin A.
@en
The treatment of lupus with cyclosporin A.
@en-gb
The treatment of lupus with cyclosporin A.
@nl
type
label
The treatment of lupus with cyclosporin A.
@ast
The treatment of lupus with cyclosporin A.
@en
The treatment of lupus with cyclosporin A.
@en-gb
The treatment of lupus with cyclosporin A.
@nl
prefLabel
The treatment of lupus with cyclosporin A.
@ast
The treatment of lupus with cyclosporin A.
@en
The treatment of lupus with cyclosporin A.
@en-gb
The treatment of lupus with cyclosporin A.
@nl
P2860
P1433
P1476
The treatment of lupus with cyclosporin A.
@en
P2093
B Griffiths
P2860
P304
P356
10.1191/096120301672970034
P50
P577
2001-01-01T00:00:00Z
P6179
1064153966